Validation of a sensitive HPLC/fluorescence method for assessment of ciprofloxacin levels in plasma and prostate microdialysate samples from rats

Biomedical Chromatography

Volumn 30, Issue 3, 2016, Pages 330-336

  Zimmermann, Estevan Sonego ^a   Torres, Bruna Gaelzer Silva ^a   Dalla Costa, Teresa ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Ciprofloxacin; Liquid chromatography fluorescence; Microdialysis; Pharmacokinetics; Validation

Indexed keywords

ACETONITRILE; ANTIBIOTICS; DIALYSIS; LIQUID CHROMATOGRAPHY; QUALITY CONTROL; RATS; UROLOGY;

ANTIBIOTIC THERAPY; BROAD SPECTRUM ANTIBIOTICS; CIPROFLOXACIN; DRUG PENETRATION; FLUORESCENCE METHOD; LIQUID CHROMATOGRAPHY/FLUORESCENCE; MICRO-DIALYSIS; MICRODIALYSATES; TRIETHYLAMINES; VALIDATION;

PHARMACOKINETICS;

CIPROFLOXACIN;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIALYSATE LEVEL; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG PENETRATION; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIMIT OF QUANTITATION; MALE; MEASUREMENT ACCURACY; MICRODIALYSIS; NONHUMAN; PRECIPITATION; PROSTATE; RAT; SENSITIVITY AND SPECIFICITY; SINGLE DRUG DOSE; VALIDATION STUDY; VOLUME OF DISTRIBUTION; ANIMAL; BLOOD; DRUG STABILITY; METABOLISM; PROCEDURES; REPRODUCIBILITY; SPECTROFLUOROMETRY; STATISTICAL MODEL; WISTAR RAT;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIPROFLOXACIN; DRUG STABILITY; LINEAR MODELS; MALE; MICRODIALYSIS; PROSTATE; RATS; RATS, WISTAR; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, FLUORESCENCE;

EID: 84956574605     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.3552     Document Type: Article

References (21)

1. Andriole VT. The quinolones: past, present, and future. Clinical Infection Diseases 2005; 41: 113-119.
2. Ball P. Quinolone generations: natural history or natural selection? Journal Antimicrobials Chemotherapy 2000; 46(suppl. T1): 17-24.
3. Bardot S, Vest P, Renard C and Renaudeau C. Determination of ciprofloxacin in human serum by high-performance liquid chromatography. Annales de Biologie Clinique 2005; 63: 513-516.
4. Drusano GL, Preston SL, Van Guilder M, North D, Gombert M, Oefelein M, Boccumini L, Weisinger B, Corrado M and Kahn J. A population pharmacokinetic analysis of the penetration of the prostate by levofloxacin. Antimicrobial Agents Chemotherapy 2000; 44: 2046-2051.
5. Elmquist WF and Sawchuk RJ. Application of microdialysis in pharmacokinetic studies. Pharmaceutical Research 1997; 14: 267-288.
6. Hurtado FK, Weber B, Derendorf H, Hochhaus G and Dalla Costa T. Population pharmacokinetic modeling of the unbound levofloxacin concentrations in rat plasma and prostate tissue measured by microdialysis. Antimicrobial Agents Chemotherapy 2014; 58: 678-686.
7. Imre S, Dogaru MT, Vari CE, Muntean T and Kelemen L. Validation of an HPLC method for the determination of ciprofloxacin in human plasma. Journal Pharmaceutical Biomedical Analysis 2003; 33: 125-130.
8. Joukhadar C, Derendorf H and Muller M. Microdialysis: a novel tool for clinical studies of anti-infective agents. European Journal of Clinical Pharmacology 2001; 57: 211-219.
9. Kamberi M, Tsutsumi K, Kotegawa T, Nakamura K and Nakano S. Determination of ciprofloxacin in plasma and urine by HPLC with ultraviolet detection. Clinical Chemestry 1998; 44: 1251-1255.
10. Konety BR, Somogyi G, Atan A, Muindi J, Chancellor MB and Getzenberg RH. Evaluation of intraprostatic metabolism of 1, 25-dihydroxyvitaminD3 (calcitriol) using a microdialysis technique. Urology 2002; 59: 947-952.
11. Lipsky BA, Byren I and Hoey CT. Treatment of bacterial prostatitis. Clinical Infection Diseases 2010; 50: 1641-1652.
12. Muchohi SN, Thuo N, Karisa J, Muturi A, Kokwaro GO and Maitland K. Determination of ciprofloxacin in human plasma using high-performance liquid chromatography coupled with fluorescence detection: application to a population pharmacokinetics study in children with severe malnutrition. Journal of Chromatography B 2011; 879: 146-152.
13. Naber KG. Management of bacterial prostatitis: what's new? BJU International 2008; 101(suppl. 3): 7-10.
14. Naber KG and Sörgel F. Antibiotic therapy - rationale and evidence for optimal drug concentrations in prostatic and seminal fluid and in prostatic tissue. Andrologia 2003; 35: 331-335.
15. Navalón A, Ballesteros O, Blanc R and Vílchez JL. Determination of ciprofloxacin in human urine and serum samples by solid-phase spectrofluorimetry. Talanta 2000; 52: 845-852.
16. Neckel U, Joukhadar C, Frossard M, Jäger W, Müller M and Mayer BX. Simultaneous determination of levofloxacin and ciprofloxacin in microdialysates and plasma by high-performance liquid chromatography. Analytica Chimica Acta 2002; 463: 199-206.
17. Png JC, Tan E, Foo KT, Cheng C and Rekhraj IR. Comparative study of the distribution of ofloxacin and ciprofloxacin in prostatic tissues after simultaneous oral ingestion. British Journal of Urology 1997; 79(5): 781-784.
18. US Food and Drug Administration. Guidance for Industry: Bioanalytical Method Validation. Washington, DC: US Food and Drug Administration, 2013.
19. Vybíralová Z, Nobilis M, Zoulova J, Kvétina J and Petr P. High-performance liquid chromatographic determination of ciprofloxacin in plasma samples. Journal of Pharmaceutical and Biomedical Analysis 2005; 37: 851-858.
20. Wagenlehner FM and Naber KG. Fluoroquinolone antimicrobial agents in the treatment of prostatitis and recurrent urinary tract infections in men. Current Infection Diseases Reports 2005; 7(1): 9-16.
21. Wu SS, Chein CY and Wen YH. Analysis of ciprofloxacin by a simple high-performance liquid chromatography method. Journal of Chromatographic Science 2008; 46: 490-495.